Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Alterity Therapeutics: Treating Neurodegenerative Diseases?

August 5, 2020 0

When a small firm’s stock price soars, and more than doubles, curiosity pushes us to investigate. …

Regenxbio: Positive One-Year Data from the Firm’s Gene Therapy RGX-314 for Wet AMD

August 4, 2020 0

Regenxbio Positive Data for RGX-314 Regenxbio (RGNX) reported positive one-year data from patients in Cohorts 4 …

Compugen: A Stock To Keep

August 3, 2020 0

Compugen Compugen (CGEN) cancer immunotherapy’s predictive target computational discovery platforms enabled it to identify two checkpoint …

Inovio: Good News About the Firm’s COVID-19 Vaccine’s Capability and Durability

July 30, 2020 0

Inovio Inovio’s COVID-19 Vaccine INO-4800 Accomplished the Following: Durable antibody and T cell responses in rhesus …

Edesa Biotech Stock Price Soared. Will It Continue to Rise?

July 30, 2020 0

Edesa Biotech Filed an IND for EB05 Edesa Biotech (EDSA), a clinical-stage biopharmaceutical company, has filed …

Moderna News. See Also: Regeneron Antibody Cocktail Could Reach the Market in October

July 29, 2020 0

SARS-CoV-2 Virus Vaccines Moderna On Monday Moderna (MRNA) started its Phase 3 clinical trial on 30,000 …

The FDA Approved Gilead Sciences CAR T Cell Product Tecartus for Adults with Relapsed or Refractory Mantle Cell Lymphoma

July 27, 2020 0

Gilead Sciences CAR T Cell Product Tecartus Gets FDA Approval The U.S. FDA approved Kite - …

TCR2 Therapeutics Encouraging Oncology Results

July 27, 2020 0

TCR2 Therapeutics Announcement TCR2 Therapeutics (TCRR) – a clinical-stage immunotherapy company with a pipeline of novel T cell therapies …

Could Arbutus Biopharma’s Patent Harm Moderna?

July 24, 2020 0

Arbutus Biopharma and Moderna's Patent Challenge Arbutus Biopharma (ABUS) is a publicly-traded biopharmaceutical company dedicated to …

Jazz Pharmaceuticals: A New FDA Approval

July 22, 2020 0

People living with narcolepsy who develop cataplexy and excessive daytime sleepiness have a new treatment called Xywav, …

The Small Firm Whose Stock Soared in Yesterday’s Market

July 21, 2020 0

Firms' with COVID-19 Vaccines Stock Performance A look at the stock performance of the COVID-19 vaccine …

A New Gene Therapy Series Starts Today with Regenxbio

July 16, 2020 0

Beyond the firms that are speeding towards bringing prophylactic vaccines against the COVID-19 infection into the …

INmune Bio: A Novel Approach Towards Treating Alzheimer’s Disease

July 14, 2020 0

Alzheimer’s Disease Alzheimer’s Disease has proven very difficult to treat through many of the trials’ attempts …

There Is A Lot More To Say About the COVID-19 Vaccines

July 13, 2020 0

Pfizer and BioNTech Vaccines Were Granted FDA Fast Track Designation Against SARS-CoV-2 (COVID-19) A large Phase …

CRiSPR Therapeutics Stock is Skyrocketing

July 8, 2020 0

CRiSPR Therapeutics Rally For those who wonder why CRiSPR Therapeutics (CRSP) is soaring we remind that …

A Novel Immunotherapy Approach for the Treatment of COVID-19

July 7, 2020 0

Corvus Pharmaceuticals: FDA Granted IND Application for COVID-19 Trial The United States FDA granted approval of Corvus …

Are We Saying Goodbye to Common Sense?

July 3, 2020 2

Prohost Letter #441 Biotechnology Companies’ Evaluations Are We Saying Goodbye to Common Sense? The SARS-CoV-2 Vaccines …

Prohost Biotech’s Decision About Akero Therapeutics

July 1, 2020 0

Akero Therapeutics Today we posted good news from Akero Therapeutics (AKRO) under News & Comments. The …

Akero Therapeutics’ Product Efruxifermin Demonstrates Strong Positive Results in NASH Patients

July 1, 2020 0

Akero Therapeutics Efruxifermin Positive Results in NASH Akero Therapeutics (AKRO) results of a 16-week analysis of secondary …

We Are Not Yet in Bizarro World

June 30, 2020 0

Unclear Reasoning for the Inovio Selloff Though Inovio (INO) announced positive interim clinical data of INO-4800 …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Alterity Therapeutics: Treating Neurodegenerative Diseases?

Regenxbio: Positive One-Year Data from the Firm’s Gene Therapy RGX-314 for Wet AMD

Compugen: A Stock To Keep

Inovio: Good News About the Firm’s COVID-19 Vaccine’s Capability and Durability

Edesa Biotech Stock Price Soared. Will It Continue to Rise?

Moderna News. See Also: Regeneron Antibody Cocktail Could Reach the Market in October

The FDA Approved Gilead Sciences CAR T Cell Product Tecartus for Adults with Relapsed or Refractory Mantle Cell Lymphoma

TCR2 Therapeutics Encouraging Oncology Results

Could Arbutus Biopharma’s Patent Harm Moderna?

Jazz Pharmaceuticals: A New FDA Approval

The Small Firm Whose Stock Soared in Yesterday’s Market

A New Gene Therapy Series Starts Today with Regenxbio

INmune Bio: A Novel Approach Towards Treating Alzheimer’s Disease

There Is A Lot More To Say About the COVID-19 Vaccines

CRiSPR Therapeutics Stock is Skyrocketing

A Novel Immunotherapy Approach for the Treatment of COVID-19

Are We Saying Goodbye to Common Sense?

Prohost Biotech’s Decision About Akero Therapeutics

Akero Therapeutics’ Product Efruxifermin Demonstrates Strong Positive Results in NASH Patients

We Are Not Yet in Bizarro World